DK0716598T3 - Farmaceutiske præparater til målrettet behandling af morbus Chron og colitis ulcerosa - Google Patents

Farmaceutiske præparater til målrettet behandling af morbus Chron og colitis ulcerosa

Info

Publication number
DK0716598T3
DK0716598T3 DK94925443T DK94925443T DK0716598T3 DK 0716598 T3 DK0716598 T3 DK 0716598T3 DK 94925443 T DK94925443 T DK 94925443T DK 94925443 T DK94925443 T DK 94925443T DK 0716598 T3 DK0716598 T3 DK 0716598T3
Authority
DK
Denmark
Prior art keywords
morbus
chron
pharmaceuticals
ulcerative colitis
targeted treatment
Prior art date
Application number
DK94925443T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Posanski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0716598T3 publication Critical patent/DK0716598T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94925443T 1993-09-01 1994-08-10 Farmaceutiske præparater til målrettet behandling af morbus Chron og colitis ulcerosa DK0716598T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329503A DE4329503A1 (de) 1993-09-01 1993-09-01 Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
PCT/EP1994/002643 WO1995006464A1 (de) 1993-09-01 1994-08-10 Pharmazeutische präparate zur gezielten behandlung von morbus crohn und colitis ulcerosa

Publications (1)

Publication Number Publication Date
DK0716598T3 true DK0716598T3 (da) 2002-02-18

Family

ID=6496579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94925443T DK0716598T3 (da) 1993-09-01 1994-08-10 Farmaceutiske præparater til målrettet behandling af morbus Chron og colitis ulcerosa

Country Status (12)

Country Link
EP (2) EP1110545A3 (ja)
JP (1) JP3712005B2 (ja)
AT (1) ATE207743T1 (ja)
AU (1) AU693470B2 (ja)
CA (1) CA2170748C (ja)
CY (1) CY2340B1 (ja)
DE (2) DE4329503A1 (ja)
DK (1) DK0716598T3 (ja)
ES (1) ES2166781T3 (ja)
NZ (1) NZ271655A (ja)
PT (1) PT716598E (ja)
WO (1) WO1995006464A1 (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
ES2124926T3 (es) * 1994-03-22 1999-02-16 Nippon Kayaku Kk Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
GB2303550B (en) * 1994-06-21 1998-07-08 Danbiosyst Uk Colonic drug delivery system
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
CN1259053A (zh) * 1997-04-11 2000-07-05 藤泽药品工业株式会社 药物组合物
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
AU757343B2 (en) * 1998-09-28 2003-02-20 Capsugel Belgium Nv Enteric and colonic delivery using HPMC capsules
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
GB0525546D0 (en) * 2005-12-15 2006-01-25 Novartis Ag Organic compounds
ES2393814T3 (es) * 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
FR2933871B1 (fr) * 2008-07-18 2012-12-14 Yvery Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
WO2010122574A2 (en) * 2009-04-20 2010-10-28 Sun Pharma Advanced Research Company Ltd. Coated capsule
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
IN2012DN00781A (ja) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin
CA3098604A1 (en) * 2018-05-03 2019-11-07 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH0211514A (ja) * 1988-06-30 1990-01-16 Takara Shuzo Co Ltd スパガリン類製剤
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments

Also Published As

Publication number Publication date
ATE207743T1 (de) 2001-11-15
JPH09501939A (ja) 1997-02-25
CY2340B1 (en) 2004-02-06
AU7535494A (en) 1995-03-22
AU693470B2 (en) 1998-07-02
NZ271655A (en) 1997-09-22
EP1110545A3 (de) 2001-07-04
EP1110545A2 (de) 2001-06-27
CA2170748C (en) 2008-10-28
EP0716598B1 (de) 2001-10-31
ES2166781T3 (es) 2002-05-01
DE59409929D1 (de) 2001-12-06
CA2170748A1 (en) 1995-03-09
EP0716598A1 (de) 1996-06-19
JP3712005B2 (ja) 2005-11-02
DE4329503A1 (de) 1995-03-02
PT716598E (pt) 2002-04-29
WO1995006464A1 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
DK0716598T3 (da) Farmaceutiske præparater til målrettet behandling af morbus Chron og colitis ulcerosa
EP0632314A3 (en) Method and device for loading a film package provided with a taking lens with photographic film.
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
NO882985L (no) Offshore-anlegg for oppdrett og oppbevaring av fisk ellerandre sjoedyr.
NO893036D0 (no) Fremgangsmaate og innretning for stabilisering av en offshore-plattform.
DE69331640D1 (de) Nach-bedarf herstellung von filmen für laserablationsverfahren
DE3884291D1 (de) Phasenverzögernde Polymerfilme und polarisierende Bauteile.
NO912707D0 (no) Spole av komposittmateriale med sporforsynt basislag, og beregnet for optisk kabel.
DE3887977D1 (de) Buten-1-Polymer-Film und damit laminierter Film.
DE68914361D1 (de) Mehrzahl von Dünnfilmfeldeffekttransistoren und Verfahren zu ihrer Herstellung.
DK0627161T3 (da) Anvendelse af L-carnitin og alkanoyl L-carnitiner til opbevaring af blod til trandfusioner og stabiliserende opløsninger in
KR960701745A (ko) 박막형성장치 및 박막형성방법(thin film forming apparatus and thin film forming method)
DE69101219D1 (de) Lipase enthaltendes flüssiges einweichmittel und dessen verwendung.
NO894845L (no) Fremgangsmaate og materialer for mikrobiell bioomdannelse av toluen og andre fenylforbindelser.
DE68918343D1 (de) Polymere Filme.
DK0689437T3 (da) anvendelse af granisetron til behandling af post-operativ kvalme og opkastning
NO903110D0 (no) Fremgangsmaate og anordning til stabilisering av seismiskeenergikilder.
FI944909A0 (fi) Hartsia sisältäviä, biaksiaalisesti orientoituja polypropeenikalvoja, menetelmä niiden valmistamiseksi sekä niiden käyttö
RU96118929A (ru) Способ повышения защитных свойств организма при воздействии внешних физических факторов
EP0239100A3 (en) Tinted heat-shrinkable multilayer films comprising a vinylidene chloride-vinyl chloride copolymer
ES2165501T3 (es) Derivados de bencimidazol sustituidos en posicion 2 como inhibidores de la proliferacion de las celulas de la musculatura lisa.
NO893061D0 (no) Fremgangsmaate og utstyr for fjernfrakobling av holdere for en undervanns-konstruksjon.
NO890897D0 (no) Anordning for dreining og sammenbinding av sylinderformede gjenstander, f.eks. forballer, trestammer og lignende.
NO890999D0 (no) Stiver for neddykkede marine konstruksjoner og fremgangsmaate for reparasjon av samme.